Bank of America’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bank of America’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-115,818	Closed	-$1M	–	7252
2018 Q4	$1M	Hold	115,818	–	–	﹤0.01%	4399
2018 Q3	$1.79M	Hold	115,818	–	–	﹤0.01%	4066
2018 Q2	$1.85M	Buy	115,818 +50,745	+78%	+$751K	﹤0.01%	4032
2018 Q1	$841K	Buy	+65,073	New	+$811K	﹤0.01%	4505
2014 Q4	–	Sell	-119	Closed	-$1K	–	7801
2014 Q3	$1K	Sell	119 -239	-67%	-$2.74K	﹤0.01%	7885
2014 Q2	$5K	Sell	358 -358	-50%	-$3.89K	﹤0.01%	7647
2014 Q1	$7K	Sell	716 -4,299	-86%	-$48.3K	﹤0.01%	7281
2013 Q4	$49K	Sell	5,015 -716	-12%	-$6.43K	﹤0.01%	6568
2013 Q3	$57K	Hold	5,731	–	–	﹤0.01%	6344
2013 Q2	$48K	Buy	+5,731	New	+$69.5K	﹤0.01%	6580

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America's IRWD Position: Q1 2026 in Review

Bank of America reduced its Ironwood Pharmaceuticals (IRWD) stake by 25% in Q1 2026, selling an estimated $11.6M and leaving 8,682,907 shares worth $30.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Bank of America first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.8M in Q4 2025. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Bank of America held 8,682,907 shares of Ironwood Pharmaceuticals worth $30.5M as of Q1 2026.
Bank of America sold 2,838,753 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $11.6M.
Ironwood Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2021 holding.
Bank of America first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Bank of America's Ironwood Pharmaceuticals position peaked at $38.8M in Q4 2025.
227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.